Predicate Research Report · generated 2026-08-21 · Print / save as PDF · Save to account
JCM — Predicate Candidate Screening
12 FDA 510(k) clearances under this product code; the 50 most recent screened below.
75 daysmedian FDA review time
259 days90th percentile
12clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K053031 | EXTENDSURE HBFASC CONTROL | Cantebury Scientific , Ltd. | 2005-12-07 | 41 | 0 |
| K011389 | HEMOGLOBIN F & A2 CONTROL (BETA-THALASSAEMIA CONTROL) | Canterbury Health Laboratories | 2001-06-21 | 45 | 0 |
| K983704 | MODIFICATION TO ABUSCREEN ONLINE FOR PHENCYCLIDINE | Roche Diagnostic Systems, Inc. | 1999-02-10 | 112 | 0 |
| K942222 | QUIK-SEP QUANTITIVE HEMOGLOBIN S CONTROLS | Isolab, Inc. | 1995-01-20 | 259 | 0 |
| K933086 | AFSC HEMO CONTROL #5331, AA2 HEMO CONTROL #5328 | Helena Laboratories | 1994-10-31 | 495 | 0 |
| K931234 | HEMOCARD CONTROL HB-AA, AE, FAA, FAE | Isolab, Inc. | 1993-05-11 | 62 | 0 |
| K924173 | HEMOCARD(TM) CONTROL | Isolab, Inc. | 1992-12-01 | 104 | 0 |
| K913427 | SICKLE HEMOGLOBIN (HBA/S) CONTROL SET | Creative Laboratory Products, Inc. | 1991-11-19 | 110 | 0 |
| K911347 | LYPHOCHEK(R) HEMOGLOBIN A2 CONTROL | Bio-Rad | 1991-06-10 | 75 | 0 |
| K910431 | HEMOCARD CONTROL | Isolab, Inc. | 1991-03-11 | 38 | 0 |
| K820787 | HELENA ABNORMAL HBA2 QUIK COLUMN CONTROL | Helena Laboratories | 1982-04-08 | 16 | 0 |
| K820037 | SICKLE-CHECK | Diagnostic Technology, Inc. | 1982-02-04 | 28 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda